Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
01/2011
01/19/2011CN101948430A Sinomenine derivative and preparation method and applications thereof
01/19/2011CN101362731B Heterocyclic compounds and methods of use
01/18/2011US7872128 6-chloro-N-(pyrimidin-5-yl)-3-(3-(trifluoromethyl)phenylamino)benzo[d]isoxazole-7-carboxamide; autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases
01/18/2011US7872126 Tetrahydroquinoline derivatives and a process for preparing the same
01/18/2011US7872039 3-aminoindazoles
01/18/2011US7872034 Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
01/18/2011US7872032 1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof
01/18/2011US7872006 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders
01/18/2011US7872005 2-substituted heteroaryl compounds
01/18/2011US7872004 Therapy, propjylxis of aids; side effect reduction
01/18/2011US7872003 Anticancer agents; kinase inhibitor; immunotherapy; viricides; antiinflammatory agents
01/18/2011US7872002 Therapeutic pyrazoloquinoline derivatives
01/18/2011CA2573219C Hepatitis c inhibitor dipeptide analogs
01/18/2011CA2491895C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
01/18/2011CA2462374C Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
01/18/2011CA2416874C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
01/18/2011CA2311125C Apoptosis inhibitor
01/13/2011WO2011005674A1 Dual-acting pyrazole antihypertensive agents
01/13/2011WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
01/13/2011WO2011003796A1 Pyridazine compounds for controlling invertebrate pests
01/13/2011WO2011003793A1 Pyridazine compounds for controlling invertebrate pests
01/13/2011WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry
01/13/2011WO2010084402A3 Heterocyclic compounds as phosphodiesterase inhibitors
01/13/2011WO2010077101A4 Novel thiazolidinedione derivative and use thereof
01/13/2011US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
01/13/2011US20110009629 Preparation of morpholine derivatives
01/13/2011US20110009628 Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same
01/13/2011US20110009626 Aminoquinoline derivatives and their use as adenosine a3 ligands
01/13/2011US20110009625 Novel compounds
01/13/2011US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
01/13/2011US20110009620 4-Amino-5-cyanopyrimidine derivatives
01/13/2011US20110009584 Romp-Polymerizable Electron Transport Materials Based On A Bis-Oxadiazole Moiety
01/13/2011US20110009438 Substituted isoxazoline compound and pest control agent
01/13/2011US20110009428 Novel androgens
01/13/2011US20110009421 Compound having 6-membered aromatic ring
01/13/2011US20110009418 Therapeutic agents useful for treating pain
01/13/2011US20110009410 Apoptosis signal-regulating kinase inhibitors
01/13/2011US20110009409 Dual-acting pyrazole antihypertensive agents
01/13/2011US20110009408 Methods for identifiying inhibitors against viruses that use a class i fusion protein
01/13/2011US20110009407 Pyridinone antagonists of alpha-4 integrins
01/13/2011US20110009406 Tetrahydro-1h-pyrrolo fused pyridones
01/13/2011US20110009405 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
01/13/2011US20110009403 2-morpholinylpurines as inhibitors of pi3k
01/13/2011US20110009402 Cyclic Inhibitors of 11Beta-Hydroxysteroid Dehydrogenase 1
01/13/2011US20110009398 p27 Protein Inducer
01/13/2011US20110009396 Tricyclic compounds for the treatment of inflammatory disorders
01/13/2011US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application
01/13/2011US20110009384 Fused ring compounds as partial agonists of ppar-gamma
01/13/2011US20110009379 Indolinone compound
01/13/2011US20110009377 Azetidine derivatives, their preparation and their application in therapy
01/13/2011US20110009362 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof
01/13/2011US20110009263 Selected salts of 3-(5,6-dihydro-1,4,2-dioxazin-3-yl)-n-[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]pyridine-2-sulfonamide, method for the production thereof, and use thereof as herbicides and plant growth regulators
01/13/2011US20110005947 Inhibitors of jak
01/13/2011CA2767467A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use
01/13/2011CA2766343A1 Platelet-activating factor receptor antagonists
01/12/2011EP2272935A1 Ultraviolet absorbent compositions
01/12/2011EP2271644A1 Substituted piperidines as therapeutic compounds
01/12/2011EP2271643A1 Compounds
01/12/2011EP2271641A1 Fungicide hydroximoyl-heterocycles derivatives
01/12/2011EP2271629A1 Substituted pyrimidin-5-carboxamides 281
01/12/2011EP2271625A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
01/12/2011EP2271621A1 Pyridyl derivatives as cftr modulators
01/12/2011EP1797062B1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
01/12/2011EP1682138B1 Heterocyclic inhibitors of mek
01/12/2011CN1816548B Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
01/12/2011CN101945879A Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
01/12/2011CN101945865A 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases
01/12/2011CN101945864A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
01/12/2011CN101945863A Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
01/12/2011CN101945862A Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
01/12/2011CN101945856A Herbicidal pyridazinone derivatives
01/12/2011CN101945852A Azetidine derivatives, their preparation and their application in therapy
01/12/2011CN101945851A Peptidyl nitriles and use thereof as dipeptidyl peptidase i inhibitors
01/12/2011CN101941964A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
01/12/2011CN101941948A Histone deacetylase inhibitor with branched structure and synthesized through click chemistry
01/12/2011CN101941917A Amide compounds and use thereof
01/12/2011CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives
01/11/2011US7868225 Artichoke hybrid named ‘PS-H2015’
01/11/2011US7868178 4-Phenoxy-, 4-phenylthio-, 4-phenylsulfonyl- or 5-phenylsulfinyl-1-(2-pyridinyl)pyrrolidene derivatives; e.g. 3-[4-(trifluoromethyl)phenoxy]-1-[5-(trifluoromethyl)-2-pyridyl]pyrrolidine insecticides, miticides and nematocides
01/11/2011US7868034 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
01/11/2011US7868033 benzoxazoles derivatives such as 2-(4-Trifluoromethoxy-phenyl)-benzooxazole-5-carboxylic acid, used for the treatment of Alzheimer's disease, spongiform encephalopathy, polyneuropathy, cardiomyopathy, non-insulin dependent diabetes and medullary carcinoma of the thyroid
01/11/2011US7868018 such as N [3-(2-(3-trifluoromethyl)-benzoylamino -[1,6]naphthyridin-3-yl)-2,4-dichloro-phenyl]-3-trifluoromethyl-benzamide, used as antiproliferative agents or for the treatment of autoimmune diseases and nervous system disorders
01/11/2011US7868013 Cycloalkyl substituted pyrimidinediamine compounds and their uses
01/11/2011US7868010 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; absorbed less rapidly from mucosal surfaces, less reversible
01/11/2011US7868002 Deazapurines and uses thereof
01/11/2011US7868001 such as 2-(3-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl)imidazo[1,2-b]pyridazine, used for decreasing the levels of tumor necrosis factors or interleukines; treatment of inflammation, autoimmune diseases, diabetes, atherosclerosis and cancer
01/11/2011US7867992 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses
01/11/2011CA2536384C Cyclic derivatives as modulators of chemokine receptor activity
01/11/2011CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
01/11/2011CA2495455C Use of i.kappa.b-kinase inhibitors in pain therapy
01/11/2011CA2456426C New mandelic acid derivatives and their use as thrombin inhibitors
01/11/2011CA2436891C Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
01/11/2011CA2407593C Fused heteroaryl derivatives
01/11/2011CA2385592C Benzamides and related inhibitors of factor xa
01/11/2011CA2328990C N,n-disubstituted amides that inhibit the binding of integrins to their receptors
01/11/2011CA2156360C Adhesion receptor antagonists
01/06/2011WO2011002067A1 Heterocyclic compound and use thereof
01/06/2011WO2011001931A1 Novel oxadiazole derivative
01/06/2011WO2011001115A1 Novel 6-morpholin-4-yl-pyrimidin-4-(3h)-one derivatives, and the pharmaceutical preparation thereof as akt(pkb) phosphorylation inhibitors
01/06/2011WO2011001114A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors